Indefinite Delivery Contract SPE2DR25D6038

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DR25D1205 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a 30-month base period with three 30-month option periods, running through December 2036. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
The federal contract IDV award SPE2DR25D3003 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as medical supplies and equipment, to various Department of Defense (DoD) customers, the U.S. Coast Guard,...
The federal contract IDV award SPE2DR25D7059 is a $999,999,999 Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. This single-award contract runs through December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
The federal contract IDV award SPE2DR25D3007 is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract runs through December 31, 2026 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award SPE2DR25D6041, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, is a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The federal contract IDV award SPE2DR25D1022 is a single-award Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract, which runs through December...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and U.S. Naval Fleet. The contract covers a broad...
The federal contract IDV award SPE2DR25D3110 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare programs through December 2036. This IDC serves as the primary contracting vehicle for the DLA...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, has a period of performance running through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...

The federal contract IDV award SPE2DR25D6038 is a single-award, unrestricted Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen Drug Corp. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), the U.S. Coast Guard, and the U.S. Naval Fleet.

The contract covers a broad range of pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. It will serve as a primary vehicle for DLA to efficiently procure essential medical commodities to support military healthcare programs globally. The contract has a 30-month base period with three 30-month option periods, running through December 2036. This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple regional prime vendor contracts to increase the DoD's resiliency and access to vital pharmaceuticals during contingencies or natural disasters.

Generated 6/6/25, 9:45 AM